Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV | New
England Journal of Medicine Skip to main content The New England Journal of Medicine …

Importance Recent advances in treatment and prevention of HIV warrant updated
recommendations to guide optimal practice. Objective Based on a critical evaluation of new …

Background Maternal HIV infection and antiretroviral drugs (ARVs) are associated with
increased risks of adverse perinatal outcomes. The vast majority of pregnant women living …

Abstract Background The European AIDS Clinical Society (EACS) Guidelines were revised
in 2021 for the 17th time with updates on all aspects of HIV care. Key points of the …

Summary Background The World Health Organization recommends protease inhibitor (PI)-
based antiretroviral therapy (ART) as second-line and third-line regimens in pregnant …

Background Late initiation of antiretrovirals in pregnancy is associated with increased risk of
perinatal transmission and higher infant mortality. We report the final 72-week postpartum …

Background Drugs taken during pregnancy can affect maternal and child health outcomes,
but few studies have compared the safety and virological efficacy of different antiretroviral …

The human immunodeficiency virus (HIV) persists in latently infected CD4+ T cells and
integrates with the host genome until cell death. Acquired immunodeficiency syndrome …

Pregnant and breastfeeding populations are at substantial risk of acquiring HIV in some
settings, yet are underrepresented in clinical trials of new pre-exposure prophylaxis (PrEP) …

Background & Aims Data on long-term tenofovir alafenamide (TAF) therapy for pregnant
women with active chronic hepatitis B (CHB)(immune clearance and reactivation phases …